Is Sedana Medical AB (publ) a good investment? Sedana Medical AB (publ) (SEDANA.ST) is currently trading at 9.44 SEK.
Earnings Schedule: Sedana Medical AB (publ) is expected to release its next earnings report on July 17, 2026. The market consensus estimate for Forward EPS is -0.17.
No, it does not currently pay a dividend.
Sedana Medical AB (publ) is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be July 17, 2026. The company currently has a trailing EPS of -0.40.
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age; and Sedaconda Filling Adapter, a single-use medical device; FlurAbsorb Pro-L and Pro-S; FlurAbsorb and Mounts; Scavenging Tube, a one piece pre-connected tube, that is designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; and Mindray exhaust connector enables to connect the exhaust of the ventilator to an active or passive scavenging system. The company was founded in 1999 and is headquartered in Danderyd, Sweden.
| Split Date | Split Ratio to 1 |
|---|---|
| May 26, 2021 | 4.000000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion